These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17573982)

  • 1. Patient-reported outcomes helped predict survival in multiple myeloma using partial least squares analysis.
    Viala M; Bhakar AL; de la Loge C; van de Velde H; Esseltine D; Chang M; Dhawan R; Dubois D
    J Clin Epidemiol; 2007 Jul; 60(7):670-679. PubMed ID: 17573982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Descriptive and prognostic value of patient-reported outcomes: the bortezomib experience in relapsed and refractory multiple myeloma.
    Dubois D; Dhawan R; van de Velde H; Esseltine D; Gupta S; Viala M; de la Loge C
    J Clin Oncol; 2006 Feb; 24(6):976-82. PubMed ID: 16432077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bortezomib is associated with better health-related quality of life than high-dose dexamethasone in patients with relapsed multiple myeloma: results from the APEX study.
    Lee SJ; Richardson PG; Sonneveld P; Schuster MW; Irwin D; San Miguel JF; Crawford B; Massaro J; Dhawan R; Gupta S; Anderson KC
    Br J Haematol; 2008 Nov; 143(4):511-9. PubMed ID: 18986387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationships among physiologic variables, quality of life, and fatigue in patients with multiple myeloma.
    Booker R; Olson K; Pilarski LM; Noon JP; Bahlis NJ
    Oncol Nurs Forum; 2009 Mar; 36(2):209-16. PubMed ID: 19273410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of patient's self-reported social functioning as an independent prognostic factor for survival in metastatic colorectal cancer patients: results of an international study by the Chronotherapy Group of the European Organisation for Research and Treatment of Cancer.
    Efficace F; Innominato PF; Bjarnason G; Coens C; Humblet Y; Tumolo S; Genet D; Tampellini M; Bottomley A; Garufi C; Focan C; Giacchetti S; Lévi F;
    J Clin Oncol; 2008 Apr; 26(12):2020-6. PubMed ID: 18421055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of regression trees, logistic regression, generalized additive models, and multivariate adaptive regression splines for predicting AMI mortality.
    Austin PC
    Stat Med; 2007 Jul; 26(15):2937-57. PubMed ID: 17186501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma.
    Cocks K; Cohen D; Wisløff F; Sezer O; Lee S; Hippe E; Gimsing P; Turesson I; Hajek R; Smith A; Graham L; Phillips A; Stead M; Velikova G; Brown J;
    Eur J Cancer; 2007 Jul; 43(11):1670-8. PubMed ID: 17574838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bortezomib in combination with conventional chemotherapeutic agents for multiple myeloma compared with bortezomib alone.
    Min CK; Lee MJ; Eom KS; Lee S; Lee JW; Min WS; Kim CC; Kim M; Lim J; Kim Y; Han K
    Jpn J Clin Oncol; 2007 Dec; 37(12):961-8. PubMed ID: 18156171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Weekly treatment with bortezomib for patients with recurrent or refractory multiple myeloma: a phase 2 trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD; Spigel DR; Barton J; Farley C; Schreeder M; Hon J; Greco FA
    Cancer; 2008 Aug; 113(4):765-71. PubMed ID: 18543319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and immunohistochemical features associated with a response to bortezomib in patients with multiple myeloma.
    Dawson MA; Opat SS; Taouk Y; Donovan M; Zammit M; Monaghan K; Horvath N; Roberts AW; Prince HM; Hertzberg M; McLean CA; Spencer A
    Clin Cancer Res; 2009 Jan; 15(2):714-22. PubMed ID: 19147779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptoms and patient-reported well-being: do they predict survival in malignant pleural mesothelioma? A prognostic factor analysis of EORTC-NCIC 08983: randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma.
    Bottomley A; Coens C; Efficace F; Gaafar R; Manegold C; Burgers S; Vincent M; Legrand C; van Meerbeeck JP;
    J Clin Oncol; 2007 Dec; 25(36):5770-6. PubMed ID: 18089874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of health-related quality-of-life data in predicting survival in patients with anaplastic oligodendrogliomas, from a phase III EORTC brain cancer group study.
    Mauer ME; Taphoorn MJ; Bottomley A; Coens C; Efficace F; Sanson M; Brandes AA; van der Rijt CC; Bernsen HJ; Frénay M; Tijssen CC; Lacombe D; van den Bent MJ;
    J Clin Oncol; 2007 Dec; 25(36):5731-7. PubMed ID: 18089867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multivariate analysis of laryngeal fluorescence spectra recorded in vivo.
    Eker C; Rydell R; Svanberg K; Andersson-Engels S
    Lasers Surg Med; 2001; 28(3):259-66. PubMed ID: 11295762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting patient survival from microarray data by accelerated failure time modeling using partial least squares and LASSO.
    Datta S; Le-Rademacher J; Datta S
    Biometrics; 2007 Mar; 63(1):259-71. PubMed ID: 17447952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of patient-reported outcomes in cancer clinical trials.
    Gotay CC; Kawamoto CT; Bottomley A; Efficace F
    J Clin Oncol; 2008 Mar; 26(8):1355-63. PubMed ID: 18227528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vision survival after open globe injury predicted by classification and regression tree analysis.
    Schmidt GW; Broman AT; Hindman HB; Grant MP
    Ophthalmology; 2008 Jan; 115(1):202-9. PubMed ID: 17588667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predicting depression in rheumatoid arthritis: the signal importance of pain extent and fatigue, and comorbidity.
    Wolfe F; Michaud K
    Arthritis Rheum; 2009 May; 61(5):667-73. PubMed ID: 19404997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of prognostic clinical and ECG parameters in patients after myocardial infarction by applying logistic regression method.
    Urbonaviciene G; Urbonavicius S; Vorum H; Bluzaite I; Jarusevicius G; Honoré B; Tamosiunaite M
    Pacing Clin Electrophysiol; 2008 Nov; 31(11):1391-8. PubMed ID: 18950295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aortic valve replacement in isolated severe aortic stenosis with left ventricular dysfunction: long-term survival and ventricular recovery.
    Rabus MB; Kirali K; Kayalar N; Tuncer EY; Toker ME; Yakut C
    Anadolu Kardiyol Derg; 2009 Feb; 9(1):41-6. PubMed ID: 19196573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.